Physician profile
Brittany Jones
NPI 1912430836
$5,129.79
in general payments reported to CMS, 2019-2025
22 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $35.34 · 2021: $235 · 2022: $1,416 · 2023: $969 · 2024: $721 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,243.77 | 2022-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $489.56 | 2019-2024 | Myday Contact Lens |
| Abbvie INC. | $435.87 | 2022 | |
| Harrow Eye, LLC | $427.65 | 2024-2025 | Vevye |
| Alcon Vision LLC | $395.66 | 2019-2025 | Precision7, Total30 |
| Johnson & Johnson Vision Care, INC. | $343.09 | 2022-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $315.89 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $230.04 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $202.25 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $162.35 | 2023-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $135.71 | 2022 | |
| Allergan, INC. | $131.64 | 2022 | |
| Mallinckrodt Hospital Products INC. | $124.80 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $114.76 | 2022 | |
| Rxsight INC | $100.00 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hoffmann-La Roche Limited | $88.65 | 2019 | |
| Abb Con-Cise Optical Group LLC | $64.66 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Visioneering Technologies, INC. | $39.86 | 2019-2020 | |
| Astellas Pharma US INC | $31.30 | 2025 | Izervay |
| Kala Pharmaceuticals, INC. | $22.10 | 2022 | |
| Shire North American Group INC | $20.74 | 2019 | |
| Biotissue Holdings INC. | $9.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.